Common blood pressure drugs may improve ulcerative colitis therapy
View as a Web Page
News Medical
 
  Bowel Cancer Bowel Cancer logo  
  The latest bowel cancer news from News Medical  
 Researchers discover bacterial molecule that rapidly repairs intestinal damageResearchers discover bacterial molecule that rapidly repairs intestinal damage
 
Scientists at Rutgers Health have discovered a molecule produced by "good" gut bacteria that rapidly heals the intestinal lining, protecting against severe inflammatory diseases and triggering increased production of a coenzyme whose levels diminish with age.
 
 
 Common blood pressure drugs may improve ulcerative colitis therapyCommon blood pressure drugs may improve ulcerative colitis therapy
 
A class of blood pressure medications may improve a widely used treatment for ulcerative colitis, the most common type of inflammatory bowel disease, suggests a new study, led by Northwestern Medicine and Kiel University in Germany, of thousands of patients with the disease.
 
   Tobacco use independently linked to anorectal sensorimotor dysfunction and fecal incontinenceTobacco use independently linked to anorectal sensorimotor dysfunction and fecal incontinence
 
Tobacco use is independently associated with anorectal sensorimotor dysfunction and fecal incontinence, according to a recent study published ahead of print in The American Journal of Gastroenterology.
 
   Beyond food: Bran-based gels show potential for targeted drug deliveryBeyond food: Bran-based gels show potential for targeted drug delivery
 
When it comes to colon health, the benefits of wheat and rye bran in wholegrain foods are well-known. Now researchers in Sweden have shown how these fibers may have a therapeutic use, too.
 
 What staying up late could mean for your gut health
 
What staying up late could mean for your gut healthLate sleep and eating patterns were associated with gut microbiome shifts, increased intestinal permeability, and metabolic inflammation in adults with obesity.
 
 
 DNA methylation profiling stratifies recurrence risk in low-grade endometrial cancer
 
DNA methylation profiling stratifies recurrence risk in low-grade endometrial cancerMolecular diagnostic approaches are expanding what information is available for clinicians and laboratory professionals, including uncovering antimicrobial resistance, identifying pathogens missed by conventional methods, revealing cancer recurrence risks and characterizing complex tumor biology.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney

Copyright © 2000-2026